RxSight COO Ilya Goldshleger sells $14,205 in company stock By Investing.com
When the U.S. Food and Drug Administration approved bemotrizinol (BEMT) as a sunscreen filter on June 9, the entire Ultra Violette office in Melbourne, Australia, erupted screaming. Stateside, the La Roche-Posay group chat exploded with
